fda compounding semaglutide news november 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounded Semaglutide: Safety & Regulation

Information contained herein is a summary of publicly available scientific literature and does not constitute medical advice

While these observations are supportive of GLP-1RA use in liver cirrhosis, prospective studies are needed to confirm this

(Urbina et al., Clinical Obesity 2026)

Data extraction and processing We analyzed FAERS reports from 2005 Q2 to 2024 Q3

Surgical Options for Gynecomastia After Weight Loss For individuals seeking gynecomastia treatment following weight loss, various surgical interventions are available to successfully remove surplus breast tissue and achieve a more contoured chest profile

Phase Phase 6 Maximum dose Weeks Weeks 21+ Dose 15 mg once weekly Notes Maximum FDA-approved dose